InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hollingsworth Jane H, Director. Officer active across 2 companies, notably Diffusion Pharmaceuticals Inc.. Cumulatively, 8 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €33k. Activity tracked since 13 May 2021. The latest transaction was filed on 13 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
122 sharesCommon StockSEC:0001437749-23-025311:0
183 sharesCommon StockSEC:0001437749-23-016502:0
183 sharesCommon StockSEC:0001437749-23-005435:0
183 sharesCommon StockSEC:0001437749-22-028356:0
183 sharesCommon StockSEC:0001437749-22-021841:0
183 sharesCommon StockSEC:0001437749-22-014181:0
32,786 shares@ US$0.6150.0% of flowCommon StockSEC:0001437749-21-012537:0
Ideal exit: 7 Feb 2022 (T+270)
32,786 shares@ US$0.6150.0% of flowCommon StockSEC:0001437749-21-012537
Ideal exit: 7 Feb 2022 (T+270)
8 of 8 declarations
About Hollingsworth Jane H
Jane H. Hollingsworth is a Board Member at Diffusion Pharmaceuticals Inc. She brings expertise in biotechnology and product development. Her role on the board allows her to contribute to the strategy and governance of the company. Jane is recognized for her ability to integrate scientific innovations into business development.
